Metraipolis › archive › dc_f40c8288938d
SLC39A6 as a pan-cancer promising biomarker and actionable therapeutic target for CH5132799 sensitivity — Europe PMC PMID:42151900
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42151900
- DOI
- 10.1186/s12885-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T05:27:15.966Z
- SHA-256 of the archived text
c30e79fa00bff83303acf75a9b90ae97e6985a3a55c1308f1770f2be95b3aeb6- Stable URL of this page
https://metraipolis.com/documento/dc_f40c8288938d
How to cite
SLC39A6 as a pan-cancer promising biomarker and actionable therapeutic target for CH5132799 sensitivity — Europe PMC PMID:42151900 — Europe PMC (en), https://europepmc.org/article/MED/42151900 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f40c8288938d (Metraipolis archive dc_f40c8288938d, sha256 c30e79fa00bff83303acf75a9b90ae97e6985a3a55c1308f1770f2be95b3aeb6)
BibTeX
@misc{dcf40c8288938d,
title = {SLC39A6 as a pan-cancer promising biomarker and actionable therapeutic target for CH5132799 sensitivity — Europe PMC PMID:42151900},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42151900},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f40c8288938d; sha256 c30e79fa00bff83303acf75a9b90ae97e6985a3a55c1308f1770f2be95b3aeb6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42151900. Agents can read the archived copy with the MCP tool read_document.